Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity

Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue fr...

Full description

Saved in:
Bibliographic Details
Published inMolecular nutrition & food research Vol. 62; no. 3
Main Authors Moreno‐Navarrete, José María, Serino, Matteo, Blasco‐Baque, Vincent, Azalbert, Vincent, Barton, Richard H., Cardellini, Marina, Latorre, Jèssica, Ortega, Francisco, Sabater‐Masdeu, Mònica, Burcelin, Rémy, Dumas, Marc‐Emmanuel, Ricart, Wifredo, Federici, Massimo, Fernández‐Real, José Manuel
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.02.2018
Wiley-VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through 1H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA1c and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA1c, or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Conclusion Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate. This figure indicates the association among Ruminococcaceae family, plasma acetate levels, SAT expression of browning‐related genes and insulin sensitivity, suggesting that increased Ruminococcaceae‐enhanced acetate biosynthesis might promote SAT browning and systemic insulin sensitivity in morbidily obese subjects.
AbstractList Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects ( n = 34). Plasma acetate is measured through 1 H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA 1c and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes ( PRDM16 , UCP1 , and DIO2 ) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16 , UCP1 , and DIO2 mRNA variance after controlling for age, BMI, HbA 1c , or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Conclusion Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate.
Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through 1H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA1c and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA1c, or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Conclusion Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate. This figure indicates the association among Ruminococcaceae family, plasma acetate levels, SAT expression of browning‐related genes and insulin sensitivity, suggesting that increased Ruminococcaceae‐enhanced acetate biosynthesis might promote SAT browning and systemic insulin sensitivity in morbidily obese subjects.
Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through 1H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA1c and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA1c, or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Conclusion Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate.
To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA , or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate.
SCOPETo examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans.METHODS AND RESULTSGut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through 1 H NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA1c and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA1c , or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity.CONCLUSIONGut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate.
Scope: To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Methods and results: Gut microbiota composition and gene markers of browning are analyzed in subcutaneous (SAT) and visceral (VAT) adipose tissue from morbidly obese subjects (n = 34). Plasma acetate is measured through H-1 NMR and insulin sensitivity using euglycemic hyperinsulinemic clamp. Subjects with insulin resistance show an increase in the relative abundance (RA) of the phyla Bacteroidetes and Proteobacteria while RA of Firmicutes is decreased. In all subjects, Firmicutes RA is negatively correlated with HbA(1c) and fasting triglycerides, whereas Proteobacteria RA was negatively correlated with insulin sensitivity. Firmicutes RA is positively associated with markers of brown adipocytes (PRDM16, UCP1, and DIO2) in SAT, but not in VAT. Multivariate regression analysis indicates that Firmicutes RA contributes significantly to SAT PRDM16, UCP1, and DIO2 mRNA variance after controlling for age, BMI, HbA(1c), or insulin sensitivity. Interestingly, Firmicutes RA, specifically those bacteria belonging to the Ruminococcaceae family, is positively associated with plasma acetate levels, which are also linked to SAT PRDM16 mRNA and insulin sensitivity. Conclusion: Gut microbiota composition is linked to adipose tissue browning and insulin action in morbidly obese subjects, possibly through circulating acetate.
Author Fernández‐Real, José Manuel
Azalbert, Vincent
Ricart, Wifredo
Cardellini, Marina
Sabater‐Masdeu, Mònica
Moreno‐Navarrete, José María
Latorre, Jèssica
Federici, Massimo
Blasco‐Baque, Vincent
Serino, Matteo
Burcelin, Rémy
Barton, Richard H.
Ortega, Francisco
Dumas, Marc‐Emmanuel
Author_xml – sequence: 1
  givenname: José María
  surname: Moreno‐Navarrete
  fullname: Moreno‐Navarrete, José María
  email: jmoreno@idibgi.org
  organization: Universitat de Girona
– sequence: 2
  givenname: Matteo
  surname: Serino
  fullname: Serino, Matteo
  organization: Institut National de la Santé et de la Recherche Médicale (Inserm)
– sequence: 3
  givenname: Vincent
  surname: Blasco‐Baque
  fullname: Blasco‐Baque, Vincent
  organization: Institut National de la Santé et de la Recherche Médicale (Inserm)
– sequence: 4
  givenname: Vincent
  surname: Azalbert
  fullname: Azalbert, Vincent
  organization: Institut National de la Santé et de la Recherche Médicale (Inserm)
– sequence: 5
  givenname: Richard H.
  surname: Barton
  fullname: Barton, Richard H.
  organization: Imperial College London
– sequence: 6
  givenname: Marina
  surname: Cardellini
  fullname: Cardellini, Marina
  organization: University of Rome “Tor Vergata”
– sequence: 7
  givenname: Jèssica
  surname: Latorre
  fullname: Latorre, Jèssica
  organization: CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII)
– sequence: 8
  givenname: Francisco
  surname: Ortega
  fullname: Ortega, Francisco
  organization: CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII)
– sequence: 9
  givenname: Mònica
  surname: Sabater‐Masdeu
  fullname: Sabater‐Masdeu, Mònica
  organization: CIBEROBN (CB06/03/010) and Instituto de Salud Carlos III (ISCIII)
– sequence: 10
  givenname: Rémy
  surname: Burcelin
  fullname: Burcelin, Rémy
  organization: Institut National de la Santé et de la Recherche Médicale (Inserm)
– sequence: 11
  givenname: Marc‐Emmanuel
  surname: Dumas
  fullname: Dumas, Marc‐Emmanuel
  organization: Imperial College London
– sequence: 12
  givenname: Wifredo
  surname: Ricart
  fullname: Ricart, Wifredo
  organization: Universitat de Girona
– sequence: 13
  givenname: Massimo
  surname: Federici
  fullname: Federici, Massimo
  organization: University of Rome “Tor Vergata”
– sequence: 14
  givenname: José Manuel
  surname: Fernández‐Real
  fullname: Fernández‐Real, José Manuel
  email: jmfreal@idibgi.org
  organization: Universitat de Girona
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29105287$$D View this record in MEDLINE/PubMed
https://hal.inrae.fr/hal-02627928$$DView record in HAL
BookMark eNqFkctvEzEQxi1URB9w5YgscQGpCX6s7fUxVPQhJRSh3C3b66Uuu3awvUT57-soJUhcOM1o5jefZuY7BychBgfAW4zmGCHyaQx9mhOEBUKC4BfgDHNMZw2m9OSYE3YKznN-RIhi0tBX4JRIjBhpxRmYbqYCV96maHwsGt6F4pK2JcOtLw9wpdNPlzKMPVx0fhOzg2uf8-Tg5xS3wYcfl3UkT4MPcGGLjwHq0MFvg86jrhVXdHGwNlcxGd_Be-OyL7vX4GWvh-zePMcLsL7-sr66nS3vb-6uFsuZbRqBZ0w422lLUSuN7gUWknMruOkQM6aTUrqeMNQi3nbSGMYYN8xY3VokNG8MvQAfD7IPelCb5Eeddipqr24XS7WvIcKJkKT9jSv74cBuUvw1uVzU6LN1w6CDi1NWWHKMaItxW9H3_6CPcUqhHlIpyVAjCaOVmh-o-tuck-uPG2Ck9t6pvXfq6F0dePcsO5nRdUf8j1kVkAdg6we3-4-cWn29_v5X_AlVx6ag
CitedBy_id crossref_primary_10_1016_j_tifs_2020_01_013
crossref_primary_10_3389_fendo_2019_00413
crossref_primary_10_1038_s41598_019_48775_0
crossref_primary_10_31883_pjfns_143164
crossref_primary_10_3390_genes13091612
crossref_primary_10_1016_j_soard_2020_04_008
crossref_primary_10_1093_ajcn_nqac217
crossref_primary_10_2147_DMSO_S240728
crossref_primary_10_3389_fendo_2022_908868
crossref_primary_10_1039_C8FO02154F
crossref_primary_10_1007_s00424_023_02860_6
crossref_primary_10_3389_fphys_2018_01908
crossref_primary_10_1016_j_cej_2024_152563
crossref_primary_10_1146_annurev_publhealth_040119_094423
crossref_primary_10_1007_s12013_024_01314_9
crossref_primary_10_1007_s40618_019_01022_9
crossref_primary_10_3390_nu12030806
crossref_primary_10_1080_19490976_2021_1960135
crossref_primary_10_3390_nu10121912
crossref_primary_10_3390_nu11081943
crossref_primary_10_1289_EHP8099
crossref_primary_10_1016_j_fct_2019_110767
crossref_primary_10_3390_nu13051450
crossref_primary_10_3389_fendo_2019_00029
crossref_primary_10_3389_fphys_2019_00038
crossref_primary_10_3390_metabo10010032
crossref_primary_10_1039_D1FO02863D
crossref_primary_10_3390_cells8080795
crossref_primary_10_3390_ijms25094659
crossref_primary_10_3748_wjg_v27_i25_3837
crossref_primary_10_1053_j_gastro_2020_10_057
crossref_primary_10_37527_2022_72_2_004
crossref_primary_10_3390_biology11111556
crossref_primary_10_1016_j_psj_2020_09_089
crossref_primary_10_1007_s11154_019_09523_x
crossref_primary_10_1016_j_pharmthera_2020_107693
crossref_primary_10_1007_s40618_022_01936_x
crossref_primary_10_3390_nu12092749
crossref_primary_10_1002_mnfr_202000532
crossref_primary_10_3390_ijms24021352
crossref_primary_10_1007_s12011_023_03854_2
crossref_primary_10_36074_grail_of_science_12_04_2024_065
crossref_primary_10_1016_j_heliyon_2023_e17040
crossref_primary_10_3389_fendo_2022_869951
crossref_primary_10_3390_life10090205
crossref_primary_10_1021_acs_jafc_3c02696
crossref_primary_10_1186_s13020_021_00437_y
crossref_primary_10_3390_nu16050681
crossref_primary_10_3390_ijerph17061854
crossref_primary_10_2139_ssrn_4182276
crossref_primary_10_2174_1381612827666210804110139
crossref_primary_10_1016_j_jtherbio_2022_103386
crossref_primary_10_3390_nu15122728
crossref_primary_10_1016_j_freeradbiomed_2021_09_026
crossref_primary_10_3390_nu15020456
crossref_primary_10_3390_nu15071723
crossref_primary_10_1016_j_celrep_2020_108270
crossref_primary_10_1210_clinem_dgab921
crossref_primary_10_3389_fmicb_2022_1031498
crossref_primary_10_1016_j_metabol_2018_11_009
crossref_primary_10_3390_nu12020339
crossref_primary_10_1080_10408398_2021_1997905
crossref_primary_10_3390_ijms232113142
crossref_primary_10_3390_nu13103666
crossref_primary_10_1039_D2FO02063G
crossref_primary_10_3390_metabo10110471
crossref_primary_10_1136_bmjdrc_2023_003412
Cites_doi 10.1016/j.cmet.2017.08.019
10.3164/jcbn.16-23
10.1172/JCI86080
10.1271/bbb.80634
10.1038/oby.2011.111
10.1159/000447690
10.1155/2017/3831972
10.1038/s41598-017-02546-x
10.2337/db15-0227
10.1016/j.celrep.2016.01.026
10.1038/nmeth.1923
10.1016/j.tem.2015.07.002
10.1136/gutjnl-2011-301012
10.1038/srep13212
10.1007/s00125-015-3712-7
10.1186/s13073-016-0312-1
10.2337/dc13-1602
10.1042/CS20160263
10.1172/JCI78362
10.1016/j.cell.2015.11.004
10.1007/s00125-012-2648-4
10.1038/nrendo.2015.128
10.1126/science.aac4812
10.1093/femsle/fnv104
10.1016/j.numecd.2012.09.002
10.1016/j.mce.2015.01.042
10.1038/nature12198
10.1093/bioinformatics/btr026
10.1017/S0007114516002245
10.15252/msb.20167356
10.1016/j.cell.2013.12.021
10.1038/nature11450
10.1038/nmeth.f.303
10.1038/nature07540
10.1210/jc.2016-1797
10.1007/s00125-016-4028-y
10.3945/ajcn.110.010132
10.1210/jc.2015-3351
10.1210/en.2015-1944
10.1053/j.gastro.2014.03.001
10.1016/j.febslet.2014.09.039
10.1038/srep37589
10.1101/gr.085464.108
10.1038/ijo.2016.23
ContentType Journal Article
Copyright 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Distributed under a Creative Commons Attribution 4.0 International License
Copyright_xml – notice: 2017 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
– notice: 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: Distributed under a Creative Commons Attribution 4.0 International License
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
7QP
7T5
7T7
7TK
8FD
C1K
FR3
H94
P64
7X8
1XC
VOOES
DOI 10.1002/mnfr.201700721
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Biotechnology Research Abstracts
Technology Research Database
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

Biotechnology Research Abstracts
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Diet & Clinical Nutrition
EISSN 1613-4133
EndPage n/a
ExternalDocumentID oai_HAL_hal_02627928v1
10_1002_mnfr_201700721
29105287
MNFR201700721
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: FLORINASH consortium
– fundername: Instituto de Salud Carlos III
  funderid: PI15/01934
– fundername: Fondo Europeo de Desarrollo Regional
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OC
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHBH
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
C45
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2W
P2X
P4D
Q.N
Q11
QB0
QRW
R.K
ROL
RWI
RX1
RYL
SUPJJ
SV3
TEORI
UB1
V8K
W8V
W99
WBKPD
WIH
WIK
WJL
WNSPC
WOHZO
WXSBR
WYISQ
XG1
XV2
Y6R
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
7QP
7T5
7T7
7TK
8FD
C1K
FR3
H94
P64
7X8
1XC
VOOES
ID FETCH-LOGICAL-c4471-57ecdac3089baf717966c76bd05bbd999ef2508068d9bb5556b5bca8c07a64b3
IEDL.DBID DR2
ISSN 1613-4125
IngestDate Wed Oct 23 06:40:04 EDT 2024
Fri Aug 16 08:50:14 EDT 2024
Thu Oct 10 20:11:57 EDT 2024
Fri Aug 23 02:20:17 EDT 2024
Sat Nov 02 12:31:15 EDT 2024
Sat Aug 24 00:49:43 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords microbiota
adipose tissue
insulin sensitivity
metabolome
obesity
Metabolome
Obesity
Microbiota
Adipose tissue
Insulin sensitivity
Language English
License 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4471-57ecdac3089baf717966c76bd05bbd999ef2508068d9bb5556b5bca8c07a64b3
Notes Present address: Matteo Serino, IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4644-8532
0000-0001-9523-7024
0000-0003-2001-1121
OpenAccessLink https://hal.inrae.fr/hal-02627928
PMID 29105287
PQID 1995049253
PQPubID 2045123
PageCount 9
ParticipantIDs hal_primary_oai_HAL_hal_02627928v1
proquest_miscellaneous_1961038118
proquest_journals_1995049253
crossref_primary_10_1002_mnfr_201700721
pubmed_primary_29105287
wiley_primary_10_1002_mnfr_201700721_MNFR201700721
PublicationCentury 2000
PublicationDate February 2018
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: February 2018
PublicationDecade 2010
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Hoboken
PublicationTitle Molecular nutrition & food research
PublicationTitleAlternate Mol Nutr Food Res
PublicationYear 2018
Publisher Wiley Subscription Services, Inc
Wiley-VCH Verlag
Publisher_xml – name: Wiley Subscription Services, Inc
– name: Wiley-VCH Verlag
References 2012; 61
2015; 163
2017; 7
2015; 58
2015; 5
2017; 26
2017; 2017
2011
2013; 23
2015; 125
2015; 11
2015; 362
2016; 101
2016; 94
2015; 405
2016; 126
2015; 349
2016; 59
2012; 55
2016; 14
2014; 156
2009; 457
2015; 26
2016; 6
2009; 73
2015; 64
2017; 13
2011; 94
2012; 490
2016; 157
2016; 21
2014; 37
2016; 40
2013; 498
2016; 116
2009; 19
2011; 27
2016; 8
2010; 7
2012; 20
2014; 588
2016; 130
2014; 146
2012; 9
e_1_2_8_28_1
e_1_2_8_29_1
e_1_2_8_47_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_26_1
e_1_2_8_27_1
Ravussin Y. (e_1_2_8_6_1) 2012; 20
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_9_1
Gagen E. J. (e_1_2_8_44_1) 2015; 362
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_23_1
der Beek C. M. (e_1_2_8_24_1) 2016; 130
e_1_2_8_41_1
e_1_2_8_40_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_16_1
e_1_2_8_37_1
Pedersen H. K. (e_1_2_8_32_1) 2016; 21
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – year: 2011
– volume: 2017
  start-page: 3831972
  year: 2017
  publication-title: Oxid. Med. Cell Longev.
– volume: 64
  start-page: 2361
  year: 2015
  publication-title: Diabetes
– volume: 73
  start-page: 570
  year: 2009
  publication-title: Biosci. Biotechnol. Biochem.
– volume: 349
  start-page: 1101
  year: 2015
  publication-title: Science
– volume: 498
  start-page: 99
  year: 2013
  publication-title: Nature
– volume: 7
  start-page: 335
  year: 2010
  publication-title: Nat. Methods
– volume: 58
  start-page: 2206
  year: 2015
  publication-title: Diabetologia
– volume: 6
  start-page: 37589
  year: 2016
  publication-title: Sci. Rep.
– volume: 588
  start-page: 4223
  year: 2014
  publication-title: FEBS Lett.
– volume: 14
  start-page: 1655
  year: 2016
  publication-title: Cell Rep.
– volume: 362
  start-page: 14
  year: 2015
  publication-title: FEMS Microbiol. Lett.
– volume: 19
  start-page: 1141
  year: 2009
  publication-title: Genome Res.
– volume: 94
  start-page: 66
  year: 2016
  publication-title: Digestion
– volume: 27
  start-page: 863
  year: 2011
  publication-title: Bioinformatics
– volume: 9
  start-page: 357
  year: 2012
  publication-title: Nat. Methods
– volume: 101
  start-page: 233
  year: 2016
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 101
  start-page: 4367
  year: 2016
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 163
  start-page: 1360
  year: 2015
  publication-title: Cell
– volume: 61
  start-page: 543
  year: 2012
  publication-title: Gut
– volume: 8
  start-page: 67
  year: 2016
  publication-title: Genome Med.
– volume: 13
  start-page: 921
  year: 2017
  publication-title: Mol. Syst. Biol.
– volume: 11
  start-page: 577
  year: 2015
  publication-title: Nat. Rev. Endocrinol.
– volume: 157
  start-page: 1881
  year: 2016
  publication-title: Endocrinology
– volume: 59
  start-page: 207
  year: 2016
  publication-title: J. Clin. Biochem. Nutr.
– volume: 125
  start-page: 478
  year: 2015
  publication-title: J. Clin. Invest.
– volume: 59
  start-page: 2208
  year: 2016
  publication-title: Diabetologia
– volume: 457
  start-page: 480
  year: 2009
  publication-title: Nature
– volume: 490
  start-page: 55
  year: 2012
  publication-title: Nature
– volume: 26
  start-page: 493
  year: 2015
  publication-title: Trends Endocrinol. Metab.
– volume: 5
  start-page: 13212
  year: 2015
  publication-title: Sci. Rep.
– volume: 130
  start-page: 2073
  year: 2016
  publication-title: Clin. Sci. (Lond)
– volume: 7
  start-page: 2360
  year: 2017
  publication-title: Sci Rep.
– volume: 405
  start-page: 84
  year: 2015
  publication-title: Mol. Cell. Endocrinol.
– volume: 23
  start-page: 160
  year: 2013
  publication-title: Nutr. Metab. Cardiovasc. Dis.
– volume: 40
  start-page: 955
  year: 2016
  publication-title: Int. J. Obes. (Lond)
– volume: 116
  start-page: 451
  year: 2016
  publication-title: Br. J. Nutr.
– volume: 21
  start-page: 535
  year: 2016
  publication-title: Nature
– volume: 26
  start-page: 672
  year: 2017
  publication-title: Cell Metab.
– volume: 146
  start-page: 1470
  year: 2014
  publication-title: Gastroenterology
– volume: 55
  start-page: 2823
  year: 2012
  publication-title: Diabetologia
– volume: 20
  start-page: 736
  year: 2012
  publication-title: Obesity (Silver Spring)
– volume: 94
  start-page: 58
  year: 2011
  publication-title: Am. J. Clin. Nutr.
– volume: 156
  start-page: 304
  year: 2014
  publication-title: Cell
– volume: 126
  start-page: 2839
  year: 2016
  publication-title: J. Clin. Invest.
– volume: 37
  start-page: 1092
  year: 2014
  publication-title: Diabetes Care
– ident: e_1_2_8_10_1
  doi: 10.1016/j.cmet.2017.08.019
– ident: e_1_2_8_28_1
  doi: 10.3164/jcbn.16-23
– ident: e_1_2_8_12_1
  doi: 10.1172/JCI86080
– ident: e_1_2_8_26_1
  doi: 10.1271/bbb.80634
– volume: 20
  start-page: 736
  year: 2012
  ident: e_1_2_8_6_1
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2011.111
  contributor:
    fullname: Ravussin Y.
– ident: e_1_2_8_40_1
  doi: 10.1159/000447690
– ident: e_1_2_8_46_1
  doi: 10.1155/2017/3831972
– ident: e_1_2_8_45_1
  doi: 10.1038/s41598-017-02546-x
– ident: e_1_2_8_13_1
  doi: 10.2337/db15-0227
– ident: e_1_2_8_30_1
  doi: 10.1016/j.celrep.2016.01.026
– ident: e_1_2_8_22_1
  doi: 10.1038/nmeth.1923
– ident: e_1_2_8_5_1
  doi: 10.1016/j.tem.2015.07.002
– ident: e_1_2_8_17_1
  doi: 10.1136/gutjnl-2011-301012
– ident: e_1_2_8_21_1
– ident: e_1_2_8_34_1
  doi: 10.1038/srep13212
– ident: e_1_2_8_36_1
  doi: 10.1007/s00125-015-3712-7
– ident: e_1_2_8_7_1
  doi: 10.1186/s13073-016-0312-1
– ident: e_1_2_8_16_1
  doi: 10.2337/dc13-1602
– volume: 130
  start-page: 2073
  year: 2016
  ident: e_1_2_8_24_1
  publication-title: Clin. Sci. (Lond)
  doi: 10.1042/CS20160263
  contributor:
    fullname: der Beek C. M.
– ident: e_1_2_8_14_1
  doi: 10.1172/JCI78362
– ident: e_1_2_8_9_1
  doi: 10.1016/j.cell.2015.11.004
– volume: 21
  start-page: 535
  year: 2016
  ident: e_1_2_8_32_1
  publication-title: Nature
  contributor:
    fullname: Pedersen H. K.
– ident: e_1_2_8_42_1
  doi: 10.1007/s00125-012-2648-4
– ident: e_1_2_8_29_1
  doi: 10.1038/nrendo.2015.128
– ident: e_1_2_8_35_1
  doi: 10.1126/science.aac4812
– volume: 362
  start-page: 14
  year: 2015
  ident: e_1_2_8_44_1
  publication-title: FEMS Microbiol. Lett.
  doi: 10.1093/femsle/fnv104
  contributor:
    fullname: Gagen E. J.
– ident: e_1_2_8_4_1
  doi: 10.1016/j.numecd.2012.09.002
– ident: e_1_2_8_15_1
  doi: 10.1016/j.mce.2015.01.042
– ident: e_1_2_8_37_1
  doi: 10.1038/nature12198
– ident: e_1_2_8_20_1
  doi: 10.1093/bioinformatics/btr026
– ident: e_1_2_8_39_1
  doi: 10.1017/S0007114516002245
– ident: e_1_2_8_19_1
  doi: 10.15252/msb.20167356
– ident: e_1_2_8_11_1
  doi: 10.1016/j.cell.2013.12.021
– ident: e_1_2_8_38_1
  doi: 10.1038/nature11450
– ident: e_1_2_8_23_1
  doi: 10.1038/nmeth.f.303
– ident: e_1_2_8_18_1
  doi: 10.1038/nature07540
– ident: e_1_2_8_43_1
  doi: 10.1210/jc.2016-1797
– ident: e_1_2_8_47_1
  doi: 10.1007/s00125-016-4028-y
– ident: e_1_2_8_31_1
  doi: 10.3945/ajcn.110.010132
– ident: e_1_2_8_33_1
  doi: 10.1210/jc.2015-3351
– ident: e_1_2_8_25_1
  doi: 10.1210/en.2015-1944
– ident: e_1_2_8_3_1
  doi: 10.1053/j.gastro.2014.03.001
– ident: e_1_2_8_8_1
  doi: 10.1016/j.febslet.2014.09.039
– ident: e_1_2_8_41_1
  doi: 10.1038/srep37589
– ident: e_1_2_8_2_1
  doi: 10.1101/gr.085464.108
– ident: e_1_2_8_27_1
  doi: 10.1038/ijo.2016.23
SSID ssj0031243
Score 2.539697
Snippet Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans....
To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans. Gut...
Scope To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans....
SCOPETo examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans.METHODS...
Scope: To examine the potential relationship among gene expression markers of adipose tissue browning, gut microbiota, and insulin sensitivity in humans....
SourceID hal
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
SubjectTerms Acetates - blood
Acetic acid
Adipocytes
Adipose tissue
Adipose Tissue - physiology
Adipose Tissue - physiopathology
Adipose Tissue, White - metabolism
Adipose Tissue, White - physiopathology
Adult
Bacteria
Biomarkers
Body mass
Browning
DNA-Binding Proteins - genetics
Female
Firmicutes
Gastrointestinal Microbiome - physiology
Gene expression
Glucose
Glucose Transporter Type 4 - genetics
Human health and pathology
Humans
Hépatology and Gastroenterology
Insulin
Insulin Receptor Substrate Proteins - genetics
Insulin Resistance
insulin sensitivity
Intestinal microflora
Iodide Peroxidase - genetics
Iodothyronine Deiodinase Type II
Life Sciences
Male
Markers
metabolome
Microbiota
Middle Aged
NMR
Nuclear magnetic resonance
Obesity
Obesity, Morbid - microbiology
Obesity, Morbid - physiopathology
Proteobacteria
Regression analysis
Relative abundance
Sensitivity
Transcription Factors - genetics
Triglycerides
Uncoupling Protein 1 - genetics
Title Gut Microbiota Interacts with Markers of Adipose Tissue Browning, Insulin Action and Plasma Acetate in Morbid Obesity
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmnfr.201700721
https://www.ncbi.nlm.nih.gov/pubmed/29105287
https://www.proquest.com/docview/1995049253
https://search.proquest.com/docview/1961038118
https://hal.inrae.fr/hal-02627928
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3Lj9MwEIdHsCcuvB-BBQ0IwYXsukmcOMeKpVSIVmhVpL1FtuNoK9hktU048Ncz4zygcECCW5PYahp7Mr9xZz4DvBS6yivhZiHTw8Mkj8tQOb9uFVEsFlFU5LdOWK3T5efkw5k8-6WKv-dDTAtubBn-fc0Grs3u-Cc09KKumOfJfLnMV5LP4oxzuk5OJ35UTM7LZ9iTzwoTcuUjtVFEx_vd97zS9XPOifxTcO7rV--AFrdAj7fe5518Oepac2S__0Z1_J_fdhtuDuoU5_10ugPXXH0XgpOta_EVDgjRr7geCf73oHvftbja9jSnVqNfYNS23SEv8CJXApG-xKbCebm9bHYON36k0Yf_5DbfUBefDY9zX2GBui7xE0n6C01nOBfSIV1cNVdmW-KwjcF92Czebd4uw2Enh9Am5P1CmTlbahsLlRtdUQRJQZbNUlMKaUxJGtVVJMWUSFWZGyOlTI00VisrMp0mJn4AB3VTu0eApJikS03OoMRklsyoualypWykM2mFCuD1OJDFZc_rKHoyc1TwUy2mpxrACxrnqRFjtpfzjwWfo7iUuYrqGzU6HKdBMRj3ruCqdsFQxziA59NlMkv-r0XXrum4TcroeQrfAnjYT5_pqyKSaJIi1QAiPwn-cqPFar04nY4e_0unJ3CDPqs-2_wQDtqrzj0lMdWaZ95gfgACmxOM
link.rule.ids 230,315,783,787,888,1378,27936,27937,46306,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3fb9MwEMctGA_wwvg5MgYcCMEL2dIkTpzHaqMUaCo0FYk3y3YcUbEl05rsYX89d84PVHhAgsc6tprEvt73ruePGXsdqDIrAzvxiR7ux1lU-MK6vFWIsViIUZE7OiFfJvOv8advfKgmpL0wHR9iTLiRZbjfazJwSkgf_aKGnlclAT0JMJfSVvJbaPMRnd5wcjoSpCJ0X67GHr2WH6MzH7iNQXi0PX7LL938TlWRf0rObQXrXNBsl-nh5rvKkx-HbaMPzfVvXMf_erp77G4vUGHaraj77IatHjDvZG0beAM9RfQMlgPE_yFrP7QN5OsO6NQocDlGZZoNUI4XaDMQSkyoS5gW64t6Y2HlJhtcBgA95zsc4griYeo2WYCqCviCqv5cYQuVQ1rAi3l9qdcF9CcZPGKr2fvV8dzvD3PwTYwO0OepNYUyUSAyrUoMIjHOMmmii4BrXaBMtSWqMREkosi05pwnmmujhAlSlcQ6esx2qrqyTxigaOI20RmxEuNJPMHuusyEMKFKuQmEx94OMykvOmSH7ODMoaS3Kse36rFXONFjJyJtz6cLSW0YmhJaUVxhp4NhHcjevjeSNrYHxHWMPPZyvIyWSX-3qMrWLfVJiD6PEZzH9rr1M35ViCqNY7DqsdCtgr_cqMyXs9Px0_6_DHrBbs9X-UIuPi4_P2V3sF10xecHbKe5bO0z1FaNfu6s5ycvfBek
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3Lj9MwEIctWCTEhfcjsMCAEFzIrpvEiXOsWEqBbbVaFWlvkV8RFWxSbRMO_PXMOA8oHJDgWMdWk9jT-Y0785mxF1yVecndJCR6eJjksQ2l8_tWEcZiEUZF_uiExTKdf0o-nImzX6r4Oz7EuOFGluF_r8nAN7Y8_AkNPa9K4nkSXy6jSvIrSYryl2TR6QiQitF7-RR7dFphgr58wDby6HB3_I5buvyZkiL_VJy7AtZ7oNkNpoZ77xJPvhy0jT4w33_DOv7Pw91k13t5CtNuPd1il1x1mwVHa9fAS-gZol9hOSD877D2XdvAYt3hnBoFfodRmWYLtMMLVAqEAhPqEqZ2vam3DlZ-qsHH_-g3X-MQnw4PU19iAaqycIKa_lxhCyVDOsCLi_pCry305xjcZavZ29Wbedgf5RCaBN1fKDJnrDIxl7lWJYaQGGWZLNWWC60tilRXohaTPJU211oIkWqhjZKGZypNdHyP7VV15R4wQMkkXKpzIiUmk2SC3XWZS2kilQnDZcBeDRNZbDpgR9GhmaOC3moxvtWAPcd5HjsRZ3s-PS6oDQNTAivKb9hpf1gGRW_d24LK2jlRHeOAPRsvo13Sny2qcnVLfVJiz2P8FrD73fIZvypCjSYwVA1Y5BfBX260WCxnp-Onh_8y6Cm7enI0K47fLz8-YtewWXaZ5_tsr7lo3WMUVo1-4m3nB8vlFlM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gut+Microbiota+Interacts+with+Markers+of+Adipose+Tissue+Browning%2C+Insulin+Action+and+Plasma+Acetate+in+Morbid+Obesity&rft.jtitle=Molecular+nutrition+%26+food+research&rft.au=Moreno%E2%80%90Navarrete%2C+Jos%C3%A9+Mar%C3%ADa&rft.au=Serino%2C+Matteo&rft.au=Blasco%E2%80%90Baque%2C+Vincent&rft.au=Azalbert%2C+Vincent&rft.date=2018-02-01&rft.issn=1613-4125&rft.eissn=1613-4133&rft.volume=62&rft.issue=3&rft_id=info:doi/10.1002%2Fmnfr.201700721&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_mnfr_201700721
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1613-4125&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1613-4125&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1613-4125&client=summon